An analytical review of 24 controlled clinical trials for fibromyalgia syndrome (FMS)

Pain

Volumn 64, Issue 2, 1996, Pages 211-219

  White, Kevin P ^a   Harth, Manfred ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

fibromyalgia; outcomes; treatment; trials

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; CARISOPRODOL; CHLORMEZANONE; CLOMIPRAMINE; CYCLOBENZAPRINE; DOSULEPIN; IBUPROFEN; MAPROTILINE; NAPROXEN; PREDNISONE; S ADENOSYLMETHIONINE; ZOPICLONE;

ADULT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FIBROMYALGIA; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW;

EID: 0029878522     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3959(95)00213-8     Document Type: Review

References (30)

1. Ahles T.A., Yunus M.B., Riley S.D., Bradley, J.M. and Masi, A.T., Psychological factors associated with primary fibromyalgia syndrome. Arthritis Rheum., 27 (1984):1101-1106.
2. Bennett RM: The fibromyalgia syndrome: myofascial pain and the chronic fatigue syndrome in Textbook of Rheumatology; Kelley WN, Harris EH, Ruddy S, Sledge GB eds. 4th Edition. WB Saunders Co., Philadelphia, (1993) 471-483.
3. Bombardier, C., Tugwell, P., Sinclair, A., Dok, C., Anderson, G. and Watson Buchanon, W., Preference for endpoint measures in clinical trials: Results of structured workshops, J. Rheumatol., 9 (1982) 798-801.
4. Buckelew, S.P., Fibromyalgia: a rehabilitation approach. A review, Am. J. Phys. Med. Rehabil., 68 (1989) 37-42.
5. Burckhardt, C.S., Clark, S.R. and Bennett, R.M., The Fibromyalgia Impact Questionnaire: Development and validation, J. Rheumatol., 18 (1991) 728-733.
6. Gabriel, S.E. and Bombardier, C., Clinical trials in fibrositis: a critical review and future directions, J. Rheumatol. 16 (Suppl. 19) (1989) 177-179.
7. Goldenberg, D.L., A review of the role of tricyclic medications in the treatment of fibromyalgia syndrome, J. Rheumatol., 16 (Suppl. 19) (1989) 137-139.
8. Goldenberg, D.L., Fibromyalgia syndrome: an emerging but controversial condition, JAMA, 257 (1987) 2782-2787.
9. Goldenberg, D.L., Psychologic studies in fibrositis, Am. J. Med., 8 (suppl 3A) (1986) 67-70.
10. Goldenberg, D.L., Treatment of fibromyalgia syndrome, Rheum. Dis. Clin. North. Am., 15 (1989) 61-71.
11. Goldsmith, C.H., Smythe, H.A., Helewa, A., Interpretation and power of a pooled index, J. Rheumatol., 20 (1993) 575-578.
12. Gotzsche, P.C., Sensitivity of effect variables in rheumatoid arthritis: a meta-analysis of 130 placebo controlled NSAID trails, J. Clin. Epidemiol., 43 (1990) 1313-1318.
13. Huskisson, E.C., Assessment for clinical trials, Clin Rheum Dis, 2 (1976) 37-49.
14. Laurent, M.R., Buchanon, W.W. and Bellamy, N., Methods of assessment used in ankylosing spondylitis clinical trials, A review, Br. J. Rheumatol., 30 (1991) 326-329.
15. McCain, G.A., Nonmedicinal treatments in primary fibromyalgia, Rheum. Dis. Clin. North. Am., 15 (1989) 73-89.
16. Medline 1966-1981, 1982-1988, 1989-1993, Jan-Jun 1994.
17. Peloso, P., Bombardier, C., and Guillemin, F., A meta-analysis of controlled trials in the treatment of the fibromyalgia syndrome, Arthritis Rheum., 36 (suppl) (1993) S49.
18. Pope, J.E. and Bellamy, N., Outcome measurement in scleroderma clinical trials, Semin. Arthritis Rheum., 23 (1993) 22-33.
19. Potts, M.K. and Silverman, S.L., The importance of aspects of treatment for fibromyalgia (fibrositis): Differences between patient and physician views, Arthritis Care Res., 3 (1990) 11-18.
20. Proceedings of a Symposium. The fibrositis/fibromyalgia syndrome. Current Issues and Perspectives. Am. J. Med., 81 (3A) (1986) 1-115.
21. Proceedings: First International Conference on Fibromyalgia. London, ON. The 3rd Edward Dunlop Symposium. J. Rheumatol., 16 (suppl 19) (1989) 58-192
22. Proceedings: The Palm Springs Fibromyalgia Syndrome Symposium. J. Rheumatol., 16 (suppl 19) (1989) 1-57.
23. Simms, R.W., Felson, D.T. and Goldenberg, D.L., Development of preliminary criteria for response to treatment in fibromyalgia syndrome, J. Rheumatol., 18 (1991) 1558-1563.
24. Smythe, H.A., Nonarticular rheumatism and psychogenic musculoskeletal syndromes in Arthritis and Allied Conditions. McCarthy DJ ed. 11th Edition. Lea and Febiger, Philadelphia. (1989) 1241-1254.
25. Smythe, H.A., Gladman, A., Dagenais, P., Kraishi, M. and Blake, R., Relation between fibrositic and control site tenderness; effects of dolorimeter scale length and footplate size, J. Rheumatol., 19 (1992) 284-289.
26. Smythe, H.A. and Moldofsky, H., Two contributions to understanding of the "fibrositis" syndrome, Bull. Rheum. Dis., 28 (1977) 928-931.
27. White, K.P., Harth, M., and Teasell, R., Work disability evaluation and the fibromyalgia syndrome, Semin. Arthritis Rheum., 24 (1995) 1-12.
28. White, K.P., McCain, G.A. and Tunks E., The effects of changing the painful stimulus upon dolorimetry scores in patients with fibromyalgia, J. Musculoskel. Pain, 1 (1993) 43-58.
29. Wolfe, F., Fibromyalgia: whither treatment? J. Rheumatol., 15 (1988) 1047-1049.
30. Wolfe, F., Cathey M.A., Kleinheksel S.M., et al, Psychological status in primary fibrositis and fibrositis associated with rheumatoid arthritis. J. Rheumatol., 11 (1984) 500-506.